|
December
headlines
Return
to December article index
Plant's
genetic code deciphered
December
14
Washington Post
Capping a massive international five-year effort,
scientists have for the first time identified and placed
in order the more than 100 million letters of genetic code
that nature uses to make a plant.
The feat marks only the third time that a complex
organism has had its entire genetic code revealed, after
the recent genetic unveilings of a tiny soil-dwelling worm
and a fruit fly. (The human genetic sequence has been
largely completed, but details of that work have yet to be
published.)
The new work paints the clearest portrait yet of
flowering plants, a unique class of life that arose a mere
200 million years ago and quickly came to dominate most of
Earth's ecosystems. It sheds light on how plants
diversified and adapted, and in particular how they
overcame the special problems that come with being rooted
to a single spot, unable to flee or hide. And it reveals
that plants have an astonishing array of biological
"senses" – more, perhaps, than people have –
through which they experience and respond to the world
around them.
More practically, because all flowering plants from
broccoli and roses to towering oaks are genetically very
similar to the species of plant that was studied – a
common roadside weed in the mustard family – scientists
now have the genetic toolbox that will allow them to
tinker with an entire kingdom of life upon which all
animals, including humans, are completely dependent.
That could greatly accelerate ongoing and, in some
cases, controversial efforts to engineer crops that are
exceptionally nutritious or resistant to insects, and to
develop plants that can detoxify soil contaminants or make
novel medicines or other products in their leaves.
"It's like standing on top of a hill and seeing
gold mines everywhere," said Elliot Meyerowitz of the
California Institute of Technology in Pasadena, whose
pioneering work on the project helped reveal how silky
flowers sprout from woody stems, why different flowers
have characteristically different numbers of petals, and
how flower genes can influence the eventual size of a
plant's edible fruits.
Among many surprising findings, described in eight
articles published in this week's issues of the journals
Nature and Science, is that flowering plants have closely
related versions of many human disease genes. That
discovery is already offering clues about why certain
human diseases produce the symptoms they do. And it
suggests that plants may eventually be useful not only as
a source of novel medicines, but also as screening tools
for testing the potential usefulness of experimental
drugs.
"This is like a Rosetta stone that will allow us
to compare all other living things on Earth," said
Peter Raven, director of the Missouri Botanical Garden in
St. Louis. "It will lead us to discoveries that are
unimaginably interesting."
All this from a scraggly 8-inch-tall plant called
Arabidopsis thaliana. Plant geneticists a decade ago
selected the weed as their "model organism"
representing all 250,000 flowering plant species. Because
it grows well indoors, matures in less than two months and
produces huge numbers of seeds, a single lab group can
grow a million of them a year without a single tractor –
confirming Ralph Waldo Emerson's observation that a weed
is simply a plant whose virtues have not yet been
discovered.
In 1996, an international consortium of scientists,
including the Institute for Genomic Research in Rockville,
banded together to form the Arabidopsis Genome Initiative.
With funds from government agencies on three continents,
the group began unraveling the DNA on the weed's five
chromosomes.
The new articles show that Arabidopsis has about 26,000
genes, fewer than in most other plants and about a third
the number believed to reside in the human genome. Almost
1,000 of those are involved in photosynthesis, all stolen
from an ancient species of photosynthetic bacteria that
learned how to make energy from sunlight about 3.5 billion
years ago and at some point took up permanent residence
inside a line of cells that would become green plants.
Scientists said they were surprised to find that most
of Arabidopsis's genes are essentially copies of the
plant's original set of about 15,000 genes – indicating
that at one or more points in the plant's evolutionary
history, its entire genome accidentally doubled in size.
Although many of those duplicate genes were gradually
lost, the plant evidently kept and modified many others to
perform new and useful tasks.
Most of the genes in Arabidopsis are similar enough to
their counterparts in other plants that as scientists
identify the ones for drought and pest resistance, for
example, they'll be able to insert them into soybeans and
other crops in which they are expected to work fine.
Moreover, about 30 percent of the genes have notable
similarities to human genes, evidence of a very early
chapter of life before the forebears of plants and animals
went their independent ways about 1.6 billion years ago.
Of 289 human disease genes that the scientists focused on,
nearly half were found to have near relatives in
Arabidopsis.
For example, a gene the plant uses to respond to
ethylene gas, a volatile plant hormone, is similar to a
gene linked to Wilson's disease in people. That makes
sense, because plants use copper to transport ethylene and
the human disease involves copper metabolism as well. But
some symptoms of the disease have never been easily
attributable to copper problems, said Joseph R. Ecker, a
professor at the Salk Institute in La Jolla, Calif., who
works with Arabidopsis. Now the mustard plant findings
have given a clue that those symptoms may be related to
gas transport problems in patients with the disease gene.
Arabidopsis also devotes more than 400 genes to making
the tough walls that surround every plant cell –
structural enhancements that animal cells lack but are
crucial to plants, whose immobility leaves them no choice
but to tough it out under extreme environmental stresses.
Many cell wall components are of economic value because
they are made into paper, fibers and other products, and
scientists want to manipulate the related genes so plants
can make materials with enhanced properties.
Researchers also want to get their hands on the genes
that plants use to make "secondary compounds," a
family of about 100,000 chemicals that animal cells cannot
make and that have value as dyes, fragrances, flavorings
and drugs.
But perhaps the most fascinating insight into what it's
like to be a plant comes from the genetic baring of the
plant's complex sensory system. Scientists said they were
astounded to find that hundreds of Arabidopsis genes
encode hormone receptors, or biological antennas for
detecting signals from inside or outside the plant –
such as "seeing" sunlight in the day and
"feeling" the cold at night.
"It's all about how plants put on sunscreen in the
morning and put on their bed socks at night," said
Steve Kay of the Scripps Research Institute in La Jolla,
who studies plants' biological clocks.
It's also about how plants feel the chewing of insects
on their leaves (which they respond to by producing
insecticidal chemicals), how they detect the touch of the
wind (which triggers water retention hormones) and how
they smell gases from other plants (which can trigger
blasts of chemical warfare agents).
Plants also have many genes that work like human immune
system genes, rallying to attack bacteria and fungi when
the plant becomes aware that it has become infected.
The National Science Foundation is launching a 10-year
effort, called Project 2010, to understand what every
Arabidopsis gene does.
'Indian
Bt cotton seeds have no ill effect on goats'
December
13
Times of India
NEW DELHI - Studies conducted by government agencies on
Indian BT cotton seeds indicate that there is no
ill-effect on goats while such studies are underway on
lactating cows, buffalos, poultry and fish.
According to official sources, the commercial release
of the seeds would be considered on completion of the
studies.
Countries like the US, Australia, Mexico, Argentina,
China and South Africa have adopted BT cotton having the
gene Cry1a (C) for commercial cultivation.
Regulatory authorities in the US, Australia, Mexico,
Argentina, Spain, Canada, Japan, China, Indonesia and
South Africa have reviewed safety assessment studies
conducted on BT cotton seed of Monsanto and concluded that
BT cotton and cotton seeds posed no food, feed and
environmental safety threat.
Only one type of BT cotton seed of Monsanto having gene
Cry1a (C) has been introduced in the world and the protein
is poisonous only to the target Lepidopteran pests,
commonly known as bellworm of cotton.
Argentine
GM policy endangers investment - Monsanto
December 13
Reuters
BUENOS AIRES -
Agribusiness giant Monsanto Co may close some operations
in Argentina if the government does not loosen
restrictions on genetically modified (GM) food production,
a company official said.
Argentina's policy of
authorizing new GM products only if they have been
approved in European Union endangers Monsanto's projects
including an $8 million cotton seed processing plant joint
venture, said Miguel Potocnik, Monsanto's agriculture
director for southern Latin America.
"This investment is
in danger and if (the cotton seeds) don't get approved it
could be yet another plant that closes in Argentina,"
Potocnik told Reuters in a recent interview.
U.S.-based Monsanto
produces herbicides such as Roundup, seeds and related
genetic trait products to help farmers grow crops with
higher yields while controlling weeds, insects and
diseases.
The company's
"Roundup Ready" cotton has not been authorized
by Argentina's Agriculture Ministry, which is trying to
balance local interests with the increasing hostility
abroad toward GM products.
Organizations like
Greenpeace have rallied public sentiment, especially in
Europe, against what they derisively describe as
"Frankenstein foods" on the grounds that not
enough is known about gene-altered crops to deem them
safe.
Argentina is the world's
second-largest producer of GM crops but concern has grown
about their viability as its No. 1 trading partner Brazil
has lately stiffened its ban on GM crops and their
importation.
"The risk that
we're running is that as a country we could be left behind
in a technology that we had the opportunity to latch onto
first, and now it seems like we want to give it up,"
Potocnik said.
About 90 percent of
Argentina's 10 million-hectare soybean crop sprouts from
Monsanto's seeds.
An Agriculture Ministry
spokesman told Reuters recently that Argentina's GM policy
had allowed it to gain the upper hand over the United
States in exporting corn to Spain.
European
Greens propel agreement on GMO release law
December 12
Environment News Service
Brussels - The European Parliament and Council of
Ministers have agreed on revisions to the European Union
law on deliberate release into the environment of
genetically modified organisms (GMOs) after what have been
described as heated conciliation talks.
The deal comes over three years after proposals for the
revision emerged from the European Commission.
Green Members of the European Parliament (MEPs) are
claiming a significant victory, having won a new
requirement for national authorities to publicize the
locations not only of genetically modified crops planted
for testing but also the locations of commercially grown
crops.
This was the key remaining point of friction after the
bulk of disagreements were cleared up last month.
In an unusual twist, the final deal appears to have
been driven by an alliance of Green politicians in both
the Parliament and the Council.
Parliamentary Greens today specifically complimented
Green French Environment Minister Dominique Voynet, who
led the Council delegation to the talks. Earlier on in the
process, Green MEPs exchanged harsh words with the
Parliament's Socialist rapporteur on the directive.
Though governments have agreed to Parliament's demand
on public registers, the final text suggests that the
Greens' victory may be less than complete.
Member states will have to establish registers for both
experimental and commercial releases of GMOs, but will
have significant leeway to decide exactly how to make this
information public.
Another key outcome of the conciliation talks is
agreement on a new requirement for an already agreed ten
year limit on GMO marketing approvals. This will be
applied also to further renewals.
Biotechnology interests had campaigned strongly against
such an outcome. For genetically modified crops and
forestry reproductive material, the rule is to be slightly
softened.
Ten year approval periods will start when varieties of
plant are placed on national seed catalogues rather than
when genetically modified "events" are approved
under the deliberate release directive.
The Parliament has also won a concession from European
Union governments on establishing links between the
directive and the United Nations Cartagena Protocol on
Biosafety. The Commission is to be invited to propose ways
of implementing the protocol by July 2001.
First passed in 1990, the deliberate release law became
the focus of intense political debate as public fears
about genetically modified crops spread through Europe in
the late 1990s.
European Union governments imposed a quasi-moratorium
on new approvals of genetically modified organisms in
summer 1999, which remains in place, and the European
Commission has been forced to make supplementary proposals
for strengthened labeling and traceability of genetically
modified products.
A resolution adopted by the European Federation of
Green Parties at a November 26 meeting in Stockholm
declares, "The Green Parties of Europe acknowledge
there are scientifically justified concerns about the
safety of all foods produced through recombinant DNA
technologies and that these genetically modified foods
pose unique hazards to the health of both the consumer and
the environment."
The Green parties listed these hazards as, "the
potential for generating new toxins, carcinogens and
allergens."
Besides unique risks to humans, the Greens said, GM
foods pose unique risks to the environment: creation of
super weeds and super viruses, destruction of biodiversity
and pollution of soil.
Biotech
wheat goes under the microscope
December 11
The Oregonian
Wheat is the world's most widely eaten food grain and
the top grain traded internationally. It's a main crop in
Oregon, where the wheat grown is the product of decades of
cross-breeding and tinkering by researchers at public
land-grant universities.
Now, wheat produced through genetic engineering is on
the horizon in the Northwest.
At stake is a crop that contributed $104 million to the
state's economy in 1999.
Administrators of Oregon State University's highly
regarded wheat breeding program, responsible for
developing wheat varieties for production in Oregon, are
close to signing a research and development deal with the
chemical giant Monsanto to develop a wheat that would
resist Monsanto's Roundup herbicide.
OSU sees the agreement as a means to help develop
better wheat for Oregon farmers. The additional research
costs for OSU are minimal, according to officials, and no
money will change hands unless a commercialization
agreement is drafted, possibly years from now.
Although the actual crops could be years away,
genetically engineered wheat would profoundly affect U.S.
food supplies. Already, most processed American
supermarket foods contain genetically engineered plant
material, mostly from soybeans and corn.
But whether Roundup Ready wheat will actually come to
market is still up in the air. The international debate
about genetically modified organisms, or GMOs, is fierce,
and the international trade climate is downright hostile
to such foods.
Oregon could see key farm exports shrink. About 85
percent of the wheat grown in Oregon and the Northwest is
exported. Some of Oregon's big wheat trading partners --
particularly Japan -- strictly regulate or ban genetically
engineered products outright.
In the Northwest, scientists and the farming community
also are split about the role of biotechnology in
developing new crop strains.
Many farmers feel stuck in the middle. Some may want
the benefits of decreased weeds through Roundup Ready
strains, with the potential for significant dollar
benefits because of higher yields. But they also don't
want to be left with bins full of unmarketable grain.
"The Pacific Northwest is not prepared for general
introduction of GMOs in the wheat industry," said
Mark Hegg, a farmer from Palouse, Wash.
Farmers'
concerns
The recent costly recall of at least 300 products
contaminated with genetically engineered StarLink corn,
which has not been approved for human consumption, was the
first recall of genetically engineered food. Farmers and
producers are worried about the chaos and financial losses
that such a fiasco could create for biotech wheat.
"This was a serious breakdown in the system, and
we've gotten a chance to learn from the StarLink
debacle," said Darrell Hanavan, chairman of U.S.
Wheat Associates biotech committee. U.S. Wheat Associates
is an export trade organization based in Washington, D.C.,
with an office in Portland to serve the Japanese market.
Hanavan, based in Englewood, Colo., is also executive
director of the Colorado Wheat Administrative Committee,
the Colorado Association for Wheat Growers and the
Colorado Wheat Research Foundation.
"It may save us from some mistakes," Hanavan
said of the StarLink experience.
Keeping grain commodities separate so that genetically
modified grains don't mix with standard varieties poses a
daunting task for grain processors. North American grain
handling systems are not designed to segregate grains to
the very low tolerances for genetically engineered crops
required by Oregon's customers in Japan and Europe.
"It's going to be the real challenge," said
Jim Peterson, an OSU wheat breeder. "You have to have
absolute perfect segregation. The tests are so sensitive
they can literally pick out a few GMO seeds contaminating
several thousand bushels."
Even those who don't plant genetically engineered wheat
worry that their products will test positive because of
accidental blending or cross-pollination -- and they worry
about who will be liable. These worries are eased somewhat
by the fact that wheat does not cross-fertilize as readily
as some other crops.
"Any extra (segregation) costs will be borne by
the farmer," even those who choose not to grow GMOs,
farmer Hegg said.
Why buy altered
wheat?
Wheat prices are low, and farmers cannot afford to lose
markets. Why would a farmer opt to increase his production
with biotech wheat and pay the Roundup Ready fees with
crops already trading at a low price?
Even farmers who don't like the prospect of Roundup
Ready wheat have to control weeds, and they agree that
Roundup is one of the most efficient and environmentally
benign weed control systems available. Planting Roundup
Ready wheat would allow farmers to deal with weeds they
hadn't been able to control before.
Saving seed is perhaps the farmers' biggest issue.
Wheat is still the No. 1 crop under the farmer's control,
where seed from each crop can be saved for planting the
next year. As Stephen Jones, a Washington State University
wheat breeder, said, "That's a basic farmers'
right."
With biotech wheat, it's likely the companies would
want to protect their investment with a technology fee and
would restrict farmers from saving seed for another crop.
Hanavan of U.S. Wheat Associates estimates such tech
fees would be about $10 an acre, but Monsanto says it's
too early to tell.
Peterson at Oregon State defends Monsanto's fee:
"That's the only way Monsanto can recoup any
investment on that technology," he said. "If
there is a benefit to the farmer, they'll buy it. Monsanto
can't price it out of the market, either."
Farmer David Dechant of Fort Lupton, Colo., said he's
worried he won't be able to save seed and won't be able to
grow wheat unless he contracts with a big company and that
he will be forced to grow genetically modified wheat to
remain competitive, especially when increased production
causes a fall in the wheat price.
"I don't feel that it's right not to save
seed," Dechant said.
Peterson said farmers will have a choice.
"Basically, 98 percent of wheats developed in the
United States by public institutions are public varieties,
and nobody has proprietary rights." he said.
"They are mostly open-released, with no restrictions
on regrowing it. I don't expect that to change in the near
future, even with biotech."
University
involvement
In all, Oregon State University has 90 scientists from
six colleges involved with Center for Gene Research and
Biotechnology, using $50 million in long-term grants from
federal, state and private sources to finance genetic
engineering research.
Between 5 percent and 10 percent of the 90 researchers,
funded at the rate of $2.5 million to $5 million, are
associated with transgenic plant research that could yield
commercial crops, said Associate Dean Michael Burke of
OSU's College of Agricultural Sciences. He said most of
those 90 scientists are working on basic genetics and cell
research, and not on genetic engineering of crops.
Burke said OSU gets little financial support from
industry and that very little of its financing is tied to
the companies that one day hope to market biotech
products.
"We don't get much support from industry,"
Burke said. "Most comes from outside granting
agencies, and most of them aren't Monsantos or Duponts."
Ed Souza, a University of Idaho wheat breeder, has
signed a similar agreement with Monsanto to work on
Roundup Ready wheat.
"Who owns what, how do you pay for it? It's an
enormous issue -- serving both of those masters and
keeping everybody happy," Souza said.
Reluctant
researcher
One university wheat breeder who won't sign a
biotechnology agreement is Jones of WSU. He is chairman of
the National Wheat Crop Germplasm Committee, which advises
the federal government on the acquisition, protection and
distribution of wheat germplasm, or genetic stock.
He refuses to sign any agreements for the highly prized
wheat varieties he has developed that would result in
technology fees, royalties or any other additional cost to
wheat growers.
"Who actually owns this material?" he said.
He said he believes taxpayer-supported research
shouldn't subsidize private companies. He is opposed to
private ownership of wheat varieties and is concerned
about the effect of genetic engineering on public crop
breeding programs.
Researchers at the two other WSU wheat breeding
programs (including spring wheat), he said, are willing to
make agreements with biotech companies to work on
developing genetically modified wheat crops. Other
colleges involved in similar work include the University
of Idaho, North Dakota State University, Colorado State
University and the University of Minnesota.
Souza of the University of Idaho says there isn't a lot
of motivation right now to work on the technology.
"There is a reluctance to move ahead," Souza
said, "and Idaho wheat growers ask that we not
release it until consumer acceptance can be
guaranteed."
"The goals of the researchers and corporate
concerns aren't necessarily those of the producer (wheat
farmer)," said Hegg of Palouse, Wash. Hegg wants
Oregon, Washington and Idaho to reach a cooperative
agreement before introduction of genetically modified
wheat.
Public-private
agreements
Hanavan, chairman of the biotech committee, said
public-private research collaborations benefit both
companies and farmers.
"We see them as a partnership," he said.
"They have helped provide competition and made
available more than one source of wheat."
Peterson said public-private partnerships such as the
one between OSU and Monsanto are essential. "They
can't do it without us; we can't do it without them,"
he said.
Without these public-private agreements, Hanavan said,
wheat farmers would lose on two issues. Biotech companies
might bypass universities, eliminating the public breeding
system, which develops the best wheats. And the companies
could develop their own seed and sell it directly to
farmers, as is the case with genetically modified corn and
soybeans.
"You've got to put Roundup Ready wheat into the
best adapted wheats, which universities have developed,
rather than in inferior varieties," Hanavan said.
Peterson emphasized that if OSU eventually signs a
commercialization agreement, the university and Monsanto
will have "joint control over whatever comes
out."
OSU owns the genetic stocks, and Monsanto owns the
Roundup Ready gene. The research would be done in Wichita,
Kan.
Even if biotech wheat is marketed, Peterson said he
doesn't see blanket use of biotech wheat, mostly because
it would lose its effectiveness.
"We don't have any intention of going 100 percent
biotech," he said. "A large component will still
be non-biotech. We want to maintain options for our
growers."
Oregon's
potato crop
Growers turn their back on
Monsanto's GE potatoes
December 11
The Oregonian
Responding to consumers, Oregon potato growers have
turned their backs on Monsanto's genetically modified
NewLeaf potatoes. Oregon state and commodity spokesmen say
they don't know of any Oregon growers who planted them
this year after big potato processors refused them.
Processors in other states are shunning them as well.
Nobody in the United States is admitting they grow
them," said Oscar Gutbrod of the state's Oregon Seed
Certification Services, an agriculture professor at Oregon
State University.
"There is no known commercial interest in
them," said Will Wise, president of the Oregon Potato
Commission. "There may be some growing here and
there, but I don't know of any. It's all over."
Mark Buckingham, a Monsanto spokesman, said some small
commercial plots were in southeastern Oregon. "The
market for them" nationwide, he said, "is very
small."
"It'll come back; it's just too useful," for
a number of reasons, predicted Al Mosley, potato
specialist with the OSU Extension Service and an associate
professor.
Two years ago, Wise said, about 1 percent to 1.5
percent of Oregon potatoes were grown from Monsanto's
NewLeaf Russet Burbank seed potatoes. Genetically, the
potato was been spliced with Bt, a bacterium and natural
insecticide, so that all parts of the plant kill the
Colorado potato beetle. A newer variety, NewLeaf Plus,
both kills Colorado potato beetles -- not a huge problem
in Oregon -- and includes resistance to potato leaf-roll
virus, which is a bigger problem in the Northwest.
The majority of the dozens of federal permits issued
from 1994 to 1999 for genetically modified crops in Oregon
were for potatoes, according to state figures, but most
permits are now for grasses and other crops.
In Oregon, companies that want to grow genetically
modified plants as part of their research must obtain a
permit from the federal Animal and Plant Health Inspection
Service, which the state then reviews to ensure that the
plants do not pose a risk to Oregon agriculture and comply
with regulations such as quarantines. Oregon actually has
no regulations for biotech crops, said Nancy Osterbauer of
the Oregon Department of Agriculture.
Buyers of Oregon's potatoes -- big ones such as Lamb
Weston, J.R. Simplot (which supplies McDonald's) and
McCain Foods, as well as small ones including Kettle Foods
and Reser's -- are refusing genetically modified potatoes,
Wise said.
Many of the companies consider consumer fears in
European and Asian markets, where debate rages over
genetically engineered foods.
In Oregon, 75 percent of potatoes go to processors
where they are frozen or dried and formed into french
fries, chips and flakes. The rest go to the fresh market.
For fall 2000, Wise added, 57,000 acres were planted
with potatoes in the state, valued at $138 million.
A CLOSE COUSIN It's all in the family. Wheat, the grain
we eat, has a close cousin called jointed goatgrass, which
is a weed. So close a cousin that wheat and jointed
goatgrass can cross naturally and form partially fertile
hybrids.
As plant geneticists get ready to develop a wheat
strain that's resistant to herbicides, including Roundup,
the relationship becomes critical. Although genetically
engineered herbicide-resistant wheat could be one method
of control, what's to keep the Roundup-resistant gene from
migrating from the desirable plant to the undesirable
wild, weedy relative, transferring its herbicide
protection back to goatgrass -- creating, in effect, a
superweed that the herbicide can't kill?
Scientists say the risks of that gene flow happening
are low, but they hope to prevent them from arising in the
first place or to develop ways to cope with it.
Carol Mallory-Smith, a weed scientist at Oregon State
University, and colleagues in Oregon and Idaho received a
four-year, $900,000 grant in September to find out how
significant the risk is and to develop ways to prevent the
escape of genes from genetically modified wheat into
jointed goatgrass.
Jointed goatgrass is a big weed problem in the United
States. It costs growers millions of dollars a year in
reduced production and grain value.
Herbicides that kill jointed goatgrass also kill wheat.
Mallory-Smith's work isn't specific to Roundup Ready
wheat. She started studying the occurrence and the nature
of herbicide-resistant goatgrass, weeds that developed
some resistance on their own, before genetically modified
wheat became an issue. "It's sort of irrelevant
whether (the wheat is) GMO or traditional breeding,
because the result is the same," she said. "It
doesn't matter if it's transgenic or not" as far as
her research is concerned.
The grant is from the Initiative for Future
Agricultural and Food Systems, a federal research funding
program. Other researchers involved in the project are Bob
Zemetra, a professor and wheat breeder at the University
of Idaho; Don Morishita at University of Idaho; and Oscar
Riera-Lizarazu, assistant professor, Crop and Soil
Science, OSU.
|